Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole versus micafungin in neonates with suspected or proven candidiasis
NL-OMON41553Phase 2Not yet recruiting
- Sponsor
- Inserm
- Start
- Jul 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in invasive candidiasis and candidiasis comparing Fluconazole with Micafungin (2 arms). Primary endpoints: Time to reach target drug exposure, AUC0-24 target exposure and 2 more. Planned start Jul 2014; status: not yet recruiting.
02
Drugs
fluconazolemicafungin
03
Conditions
invasive candidiasiscandidiasis
Beyond the preview
Go deeper on NL-OMON41553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41553.